EP3426064B1 - Smokeless oral tobacco product and preparation thereof - Google Patents
Smokeless oral tobacco product and preparation thereof Download PDFInfo
- Publication number
- EP3426064B1 EP3426064B1 EP17709761.5A EP17709761A EP3426064B1 EP 3426064 B1 EP3426064 B1 EP 3426064B1 EP 17709761 A EP17709761 A EP 17709761A EP 3426064 B1 EP3426064 B1 EP 3426064B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tobacco
- particulate material
- weight
- smokeless oral
- tobacco product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000019505 tobacco product Nutrition 0.000 title claims description 169
- 241000208125 Nicotiana Species 0.000 claims description 193
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 192
- 239000011236 particulate material Substances 0.000 claims description 162
- 239000000463 material Substances 0.000 claims description 77
- 239000007799 cork Substances 0.000 claims description 70
- 239000002245 particle Substances 0.000 claims description 67
- 239000000203 mixture Substances 0.000 claims description 41
- 238000000034 method Methods 0.000 claims description 29
- 238000005029 sieve analysis Methods 0.000 claims description 28
- 235000000346 sugar Nutrition 0.000 claims description 22
- 229920002472 Starch Polymers 0.000 claims description 21
- 238000012545 processing Methods 0.000 claims description 21
- 239000008107 starch Substances 0.000 claims description 21
- 235000019698 starch Nutrition 0.000 claims description 21
- 239000010903 husk Substances 0.000 claims description 18
- 244000062793 Sorghum vulgare Species 0.000 claims description 15
- 238000010438 heat treatment Methods 0.000 claims description 15
- 235000019713 millet Nutrition 0.000 claims description 15
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 13
- 235000010443 alginic acid Nutrition 0.000 claims description 13
- 229920000615 alginic acid Polymers 0.000 claims description 13
- 230000002209 hydrophobic effect Effects 0.000 claims description 13
- 239000000661 sodium alginate Substances 0.000 claims description 13
- 235000010413 sodium alginate Nutrition 0.000 claims description 13
- 229940005550 sodium alginate Drugs 0.000 claims description 13
- 239000004793 Polystyrene Substances 0.000 claims description 11
- 229920002223 polystyrene Polymers 0.000 claims description 11
- 239000004005 microsphere Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- 239000000047 product Substances 0.000 description 42
- 230000001186 cumulative effect Effects 0.000 description 17
- 239000000796 flavoring agent Substances 0.000 description 16
- 230000000717 retained effect Effects 0.000 description 10
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 9
- 229960002715 nicotine Drugs 0.000 description 9
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 9
- 238000009928 pasteurization Methods 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 6
- 239000006260 foam Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 238000007873 sieving Methods 0.000 description 6
- 239000005715 Fructose Substances 0.000 description 5
- 229930091371 Fructose Natural products 0.000 description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 230000002411 adverse Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 230000035800 maturation Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 238000007598 dipping method Methods 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 239000002023 wood Substances 0.000 description 4
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 3
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000006172 buffering agent Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 235000012550 Pimpinella anisum Nutrition 0.000 description 2
- 240000004760 Pimpinella anisum Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 240000007436 Cananga odorata Species 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 244000267823 Hydrangea macrophylla Species 0.000 description 1
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 244000255365 Kaskarillabaum Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 241000768444 Magnolia obovata Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000016278 Mentha canadensis Nutrition 0.000 description 1
- 244000245214 Mentha canadensis Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000016977 Quercus suber Nutrition 0.000 description 1
- 240000008289 Quercus suber Species 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 229930183415 Suberin Natural products 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000013590 bulk material Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 150000005829 chemical entities Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 235000020057 cognac Nutrition 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical class OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 229910000267 dualite Inorganic materials 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- -1 sucrose and maltose) Chemical class 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
Definitions
- the present invention relates to a smokeless oral tobacco product and methods of making the same.
- Smokeless oral tobacco products comprise smokeless materials, such as smokeless tobacco, that are designed to be placed in the oral cavity of a user for a limited period of time.
- Smokeless oral tobacco products include snuff, which can be provided in dry or moist form.
- Smokeless oral tobacco products can be portioned or non-portioned.
- US patent application 2013/298920 relates to a smokeless tobacco analogue material comprising comminuted sunflower seed hulls that are processed to be tasteless and to have a consistency and feel similar or complementary to a smokeless tobacco product.
- the present invention seeks to provide an improved smokeless oral tobacco product and a method for the production thereof.
- a smokeless oral tobacco product comprising a tobacco material and a particulate material which is other than tobacco, the particulate material having the following properties:
- a method for the production of a smokeless oral tobacco product comprising a tobacco material and a particulate material which is other than tobacco, the particulate material having the following properties:
- particulate material according to claim 1 which is other than tobacco, the particulate material having the following properties:
- particulate material according to claim 1 which is other than tobacco, the particulate material having the following properties:
- particulate material which is other than tobacco
- the particulate material according to claim 1 having the following properties:
- the present invention relates to a smokeless oral tobacco product.
- the "particulate material" for use in the present invention is a particulate material which is other than tobacco.
- the smokeless oral tobacco product includes tobacco and particulate material as defined herein, wherein the particulate material is a hydrophobic particulate material selected from the group consisting of cork, sawdust, millet husks, polystyrene, sodium alginate microspheres, foamed alginates, and mixtures thereof.
- Smokeless tobacco product is used herein to denote any tobacco product which is not intended for combustion.
- Smokeless oral tobacco product is used herein to denote any smokeless tobacco product designed to be placed in the oral cavity of a user for a limited period of time, during which there is contact between the user's saliva and the product.
- smokeless oral tobacco product does not include tobacco heating products.
- a smokeless oral tobacco product can be provided to the user in a portioned or a non-portioned format. Portioned smokeless oral tobacco products can reduce or eliminate the handling of the tobacco by the user, which can offer significant advantages in terms of better hygiene, convenience and/or ease of use.
- the smokeless oral tobacco product of the present invention is a portioned product.
- the smokeless oral tobacco product comprises a tobacco material.
- tobacco material as used herein includes a material which comprises tobacco and/or a tobacco replacement or substitute.
- the tobacco material comprises tobacco.
- the tobacco material is tobacco.
- the tobacco material comprises a tobacco replacement or substitute.
- the tobacco material is a tobacco replacement or substitute.
- tobacco as used herein includes any part, such as the leaves, flowers, or stems, of any member of the genus Nicotiana and reconstituted materials thereof. In some embodiments, it includes treated tobacco. In some embodiments, it includes derivatives such as specific compounds found in natural tobacco, such as nicotine, whether extract or synthesized, as well as structural derivatives such as the fibrous portion of a tobacco leaf.
- tobacco extract includes tobacco extract.
- tobacco replacement or substitute includes tobacco substitutes which comprise individual chemicals and/or complex chemical entities which, when appropriately prepared, physically resemble natural tobacco.
- tobacco replacement or substitute includes materials which deliver nicotine to the user and provide a similar mouthfeel to tobacco.
- the amount of stem in the tobacco blend may be up to 50%, up to 60%, or up to 70% by weight of the tobacco.
- the amount of stem in the tobacco is from 5% to 70% by weight of the tobacco, such as from 10% to 65% by weight of the tobacco, such as from 15% to 65% by weight of the tobacco, such as from 20% to 60% by weight of the tobacco, such as from 25% to 55% by weight of the tobacco, such as from 30% to 50% by weight of the tobacco.
- Tobaccos used in the present invention may include types of tobaccos such as dark air-cured tobacco, flue-cured tobacco, Burley tobacco, Oriental tobacco, Maryland tobacco, dark tobacco, dark-fired tobacco and Rustica tobaccos, as well as other rare or specialty tobaccos.
- tobaccos such as dark air-cured tobacco, flue-cured tobacco, Burley tobacco, Oriental tobacco, Maryland tobacco, dark tobacco, dark-fired tobacco and Rustica tobaccos, as well as other rare or specialty tobaccos.
- the tobacco is ground tobacco and/or is in particulate form. In some embodiments, the tobacco is not in the form of strands or cut lamina.
- the tobacco may be snuff in dry or moist form.
- "Snuff” is used herein to generally describe a class of smokeless tobacco product which typically comprises cured tobacco which has been dried and ground to have mass median particle size measured by sieve analysis of between 0.01 and 5mm, such as between 0.01 and 3mm, such as between 0.01 and 1.0 mm.
- the tobacco may be dry snuff.
- the moisture content of the tobacco is less than 16% by weight of the total smokeless oral tobacco product, such as less than 12% by weight of the total smokeless oral tobacco product, such as less than 10% by weight of the total smokeless oral tobacco product, such as less than 5% by weight of the total smokeless oral tobacco product, such as less than 3% by weight of the total smokeless oral tobacco product, such as less than 2% by weight of the total smokeless oral tobacco product, such as less than 1% by weight of the total smokeless oral tobacco product.
- the tobacco is in moist form.
- the moist tobacco may be in any form that is suitable for incorporation into a smokeless oral tobacco product.
- the moist tobacco comprises moist snuff.
- the moist snuff comprises Swedish-style snuff, which may also be referred to as snus-style tobacco or snus. In some embodiments, the moist snuff is
- Snus Swedish-style snuff (snus).
- Snus is a moist powder tobacco product originating from a variant of dry snuff.
- snus is an oral tobacco product which is not fermented, but is rather heat-treated, such as by pasteurisation. Snus is typically used by placing it under the upper lip for extended periods of time.
- the moisture content of the tobacco is at least 20% by weight of the total smokeless oral tobacco product, such as at least 25% by weight of the smokeless oral tobacco product, such as at least 30% by weight of the smokeless oral tobacco product, such as at least 35% by weight of the smokeless oral tobacco product, such as at least 40% by weight of the smokeless oral tobacco product, such as at least 45% by weight of the smokeless oral tobacco product, such as at least 50% by weight of the smokeless oral tobacco product, such as at least 60% by weight of the smokeless oral tobacco product.
- the smokeless oral tobacco product comprises snus
- the snus may comprise salt and/or other flavourants.
- the snus may be pasteurised or may undergo a process similar to pasteurisation and may optionally be matured, to reach the desired pH and/or moisture content of the snus. Methods and apparatus suitable for pasteurisation and maturation are known to the person skilled in the art.
- the moist snuff may be in the form of dipping tobacco.
- the dipping tobacco may be treated by fermentation or may undergo a process similar to fermentation and may optionally undergo one or more further processes such as aging. Methods and apparatus suitable for the treatment of dipping tobacco are known to the person skilled in the art.
- the tobacco may be in the form of US moist snuff and/or chewing tobacco.
- the amount of tobacco within the tobacco formulation may vary.
- the amount of tobacco within the smokeless oral tobacco product is at least about 5% by weight of the smokeless oral tobacco product, such as at least about 10% by weight of the smokeless oral tobacco product, such as at least about 15% by weight of the smokeless oral tobacco product, such as at least about 20% by weight of the smokeless oral tobacco product, such as at least about 25% by weight of the smokeless oral tobacco product, such as at least about 30% by weight of the smokeless oral tobacco product, such as at least about 40% by weight of the smokeless oral tobacco product, such as at least about 50% by weight of the smokeless oral tobacco product, such as at least about 55% by weight of the smokeless oral tobacco product, such as at least about 60% by weight of the smokeless oral tobacco product.
- the amount of tobacco within the smokeless oral tobacco product is no greater than about 90% by weight of the smokeless oral tobacco product, such as no greater than about 85% by weight of the smokeless oral tobacco product, such as no greater than about 80% by weight of the smokeless oral tobacco product, such as no greater than about 75% by weight of the smokeless oral tobacco product, such as no greater than about 70% by weight of the smokeless oral tobacco product.
- the amount of tobacco within the smokeless oral tobacco product is between about 20% and 90% by weight of the smokeless oral tobacco product, such as between 20% and 85% by weight of the smokeless oral tobacco product, such as between about 20% and 80% by weight of the smokeless oral tobacco product, such as between about 20% and 75% by weight of the smokeless oral tobacco product, such as between about 20% and 70% by weight of the smokeless oral tobacco product, such as between about 20% and 65% by weight of the smokeless oral tobacco product, such as between about 20% and 60% by weight of the smokeless oral tobacco product, such as between about 25% and 60% by weight of the smokeless oral tobacco product, such as between about 30% and 60% by weight of the smokeless oral tobacco product, such as between about 35% and 60% by weight of the smokeless oral tobacco product.
- the smokeless oral tobacco product can be provided to the user in a portioned format.
- the tobacco material is surrounded by a pouch.
- a common method of providing moist snuff is to seal the tobacco material in a permeable pouch.
- a pouch holds the tobacco material in place, while at the same time allowing substances such as flavours and nicotine to diffuse through the pouch and into the mouth of the user for absorption through the user's mucous membranes.
- the smokeless oral tobacco product can be provided to the user in a non-portioned format.
- the smokeless oral tobacco product is packaged in loose form in a container, such as a can, sachet or tin.
- the smokeless oral tobacco product can be provided to the user in a preformed format, such as that described in EP 2649889 .
- a preformed format such as that described in EP 2649889 .
- Such a format typically does not require the use of pouches to contain the product, but may still be portioned.
- the smokeless oral tobacco product comprises a particulate material.
- the particulate material in accordance with the present invention has the following properties:
- the term "particulate” means that the average length to width ratio of particles of the material is less than 2:1, such as less than 1.5:1, such as about 1:1.
- the particles of the particulate material are substantially spherical.
- the particulate material is granular.
- the particulate material has a mass median particle size measured by sieve analysis of from about 0.3 mm to about 2.5 mm, such as from about 0.3 mm to about 2 mm, such as from about 0.3 mm to about 1.5 mm, such as from about 0.3 mm to about 1 mm, such as from about 0.3 mm to about 0.7 mm.
- the particulate material has a mass median particle size measured by sieve analysis of from about 0.4 mm to about 2.5 mm, such as from about 0.4 mm to about 2 mm, such as from about 0.4 mm to about 1.5 mm, such as from about 0.4 mm to about 1 mm, such as from about 0.4 to about 0.7 mm.
- mass median particle size is defined as the size at which one half of the total mass of all particles in a sample is contributed by particles with a size smaller than the mass median particle size, and one half of the total mass of all particles in a sample is contributed by particles with a size larger than the mass median particle size.
- the mass median particle size of the particulate material may be measured by sieve analysis.
- sieve analysis is a method used to measure the particle size distribution of a particulate material.
- sieve analysis involves a nested column of sieves which comprise screens, preferably in the form of wire mesh cloths. A pre-weighed sample may be introduced into the top or uppermost sieve in the column, which has the largest screen openings or mesh size (i.e. the largest pore diameter of the sieve). Each lower sieve in the column has progressively smaller screen openings or mesh sizes than the sieve above.
- a receiver portion to collect any particles having a particle size smaller than the screen opening size or mesh size of the bottom or lowermost sieve in the column (which has the smallest screen opening or mesh size).
- the column of sieves may be placed on or in a mechanical agitator.
- the agitator causes the vibration of each of the sieves in the column.
- the mechanical agitator may be activated for a pre-determined period of time in order to ensure that all particles are collected in the correct sieve.
- the column of sieves is agitated for a period of time from 0.5 minutes to 10 minutes, such as from 1 minute to 10 minutes, such as from 1 minute to 5 minutes, such as for approximately 3 minutes.
- the material collected on each sieve is weighed.
- the weight of each sample on each sieve may then be divided by the total weight in order to obtain a percentage of the mass retained on each sieve.
- the mass median particle size of the particulate material may be measured as follows:
- the screen opening sizes or mesh sizes for each sieve in the column used for sieve analysis may be selected based on the granularity or known maximum/minimum particle sizes of the sample to be analysed.
- a column of sieves may be used for sieve analysis, wherein the column comprises from 2 to 20 sieves, such as from 5 to 15 sieves.
- a column of sieves may be used for sieve analysis, wherein the column comprises 10 sieves.
- the screen opening or mesh sizes of the 10 sieves may be as follows for determining the mass median particle size of the particulate material: Sieve Number Mesh Size ( ⁇ m) 1 1000 2 900 3 800 4 710 5 600 6 500 7 400 8 180 9 90 10 ⁇ 90
- the density of the particulate material is defined as the bulk density of the material.
- bulk density is defined as the mass of a number of particles of the particulate material divided by the total volume they occupy.
- the term "bulk density” refers to the untapped or freely settled bulk density. In other words, bulk density is measured as the untapped density (i.e. before any specified compaction process, which may involve vibration of the container).
- the particulate material has a bulk density of less than about 0.55 g/cm 3 , such as less than about 0.5 g/cm 3 , such as less than about 0.45 g/cm 3 , such as less than about 0.4 g/cm 3 , such as less than about 0.35 g/cm 3 , such as less than about 0.3 g/cm 3 , such as less than about 0.25 g/cm 3 , such as less than about 0.2 g/cm 3 , such as less than about 0.15 g/cm 3 .
- starch is defined as a carbohydrate comprising at least 200 glucose units joined by glycosidic bonds.
- sucrose is defined as compounds selected from the group consisting of monosaccharides (such as glucose and fructose), disaccharides (such as sucrose and maltose), and oligosaccharides.
- a smokeless oral tobacco product comprising a tobacco material and a particulate material, according to claim 1 the particulate material having the following properties:
- the particulate material has a combined starch and sugar content of less than about 7% based on the weight of the particulate material.
- the particulate material has a combined starch and sugar content of less than about 6% based on the weight of the particulate material, such as less than about 5.5% based on the weight of the particulate material, such as less than about 5% based on the weight of the particulate material, such as less than about 4.5% based on the weight of the particulate material, such as less than about 4% based on the weight of the particulate material, such as less than about 3.5% based on the weight of the particulate material, such as less than about 3% based on the weight of the particulate material, such as less than about 2.5% based on the weight of the particulate material, such as less than about 2% based on the weight of the particulate material, such as less than about 1.5% based on the weight of the particulate material, such as less than about 1% based on the weight of the particulate
- the particulate material has a total sugar content of less than about 7% based on the weight of the particulate material. In some embodiments, the particulate material has a total sugar content of less than about 6% based on the weight of the particulate material, such as less than about 5.5% based on the weight of the particulate material, such as less than about 5% based on the weight of the particulate material, such as less than about 4.5% based on the weight of the particulate material, such as less than about 4% based on the weight of the particulate material, such as less than about 3.5% based on the weight of the particulate material, such as less than about 3% based on the weight of the particulate material, such as less than about 2.5% based on the weight of the particulate material, such as less than about 2% based on the weight of the particulate material, such as less than about 1.5% based on the weight of the particulate material, such as less than about 1% based on the weight of the particulate material.
- the particulate material has a total starch content of less than about 7% based on the weight of the particulate material. In some embodiments, the particulate material has a total starch content of less than about 6% based on the weight of the particulate material, such as less than about 5.5% based on the weight of the particulate material, such as less than about 5% based on the weight of the particulate material, such as less than about 4.5% based on the weight of the particulate material, such as less than about 4% based on the weight of the particulate material, such as less than about 3.5% based on the weight of the particulate material, such as less than about 3% based on the weight of the particulate material, such as less than about 2.5% based on the weight of the particulate material, such as less than about 2% based on the weight of the particulate material, such as less than about 1.5% based on the weight of the particulate material, such as less than about 1% based on the weight of the weight of the part
- the particulate material has a mass median particle size measured by sieve analysis of from about 0.3 mm to about 1 mm, a bulk density of less than about 0.4 g/cm 3 , and a combined starch and sugar content of less than about 7% based on the weight of the particulate material.
- the particulate material has a mass median particle size measured by sieve analysis of from about 0.3 mm to about 0.7 mm, a bulk density of less than about 0.25 g/cm 3 , and a combined starch and sugar content of less than about 5% based on the weight of the particulate material.
- the particulate material is selected from the group consisting of cork, sawdust, millet husks, polystyrene, sodium alginate microspheres, foamed alginates, and mixtures thereof.
- the husks or hulls of grains may encapsulate the nutritious seed of the grain and are typically a waste product of the food industry.
- the husks or hulls of grains are millet husk.
- Such husks or hulls of grains are typically hydrophilic in nature, but may be made hydrophobic for the purposes of the present invention by surface treatment.
- Foams are typically formed by trapping pockets of gas in a material.
- the foam may include open cell foam and/or closed cell foam.
- the foam is formed from alginates.
- the foam is selected from sodium alginate, or polystyrene.
- the particulate material is a foamed alginate, such as that described in WO 2014/096816 .
- the foamed alginate is foamed sodium alginate.
- the hollow particles and semispheres may be formed from polymers that are filled with air to ensure a lighter density than the bulk material.
- the hollow particles and semispheres may be selected from the group comprising Expancel (AkzoNobel), Dualite® (Henkel), and SunspheresTM (The DOW Chemical Company). Hydrophobic grades of each of these hollow particles and semispheres are available.
- the hollow particles and semispheres may also be formed from sodium alginate particles.
- the particulate material is a hydrophobic particulate material of wood or tree origin.
- the particulate material is sawdust.
- Sawdust (otherwise referred to as wood dust) is a by-product of cutting, grinding, drilling, sanding or otherwise pulverising wood. It is typically composed of fine particles of wood.
- the particulate material is cork. Cork is a prime subset of bark tissue harvested primarily from Quercus suber. Cork comprises suberin, a hydrophobic substance.
- the particulate material is a hydrophobic particulate material selected from the group consisting of cork, millet husk, polystyrene, sodium alginate microspheres, foamed alginates and mixtures thereof.
- the particulate material is cork.
- Cork is a material having a lower density than tobacco.
- the particulate material is cork, wherein the bulk density of cork is from 0.05 to 0.4 g/cm 2 , such as from 0.05 to 0.3 g/cm 3 , such as from 0.05 to 0.29 g/cm 3 , such as from 0.05 to 0.28 g/cm 3 , such as from 0.05 to 0.27 g/cm 3 , such as from 0.05 to 0.26 g/cm 3 .
- the density of the cork is from 0.05 to 0.1 g/cm 3 .
- the density of the cork is from 0.17 to 0.26 g/cm 3 .
- Figure 1 shows a chart that includes the densities measured for a number of different materials. The weight of the materials is plotted on the y-axis, where the weight was measured per cm 3 of product.
- a suitable weight ratio between the tobacco material and the particulate material in the smokeless oral tobacco product depends on the desired properties of the smokeless oral tobacco product.
- the weight ratio between the tobacco material and the particulate material will depend on the desired dryness and density of the smokeless oral tobacco product.
- the weight ratio of the particulate material to tobacco material in the smokeless oral tobacco product is from 20:1 to 1:20, such as from 15:1 to 1:15, such as from 10: 1 to 1:10, such as from 9:1 to 1:9, such as from 8:1 to 1:8, such as from 7:1 to 1:7, such as from 6:1 to 1:6, such as from 5:1 to 1:5, such as from 4:1 to 1:4, such as from 3:1 to 1:3, such as from 2:1 to 1:2.
- the particulate material is cork.
- the weight ratio of the cork to tobacco material in the smokeless oral tobacco product is from 20:1 to 1:20, such as from 15:1 to 1:15, such as from 10:1 to 1:10, such as from 9:1 to 1:9, such as from 8:1 to 1:8, such as from 7:1 to 1:7, such as from 6:1 to 1:6, such as from 5:1 to 1:5, such as from 4:1 to 1:4, such as from 3:1 to 1:3, such as from 2:1 to 1:2.
- the weight ratio of the particulate material to tobacco material in the smokeless oral tobacco product is from 1:1.5 to 1:10, such as from 1:1.5 to 1:9, such as from 1:1.5 to 1:8, such as from 1:1.5 to 1:7, such as from 1:1.5 to 1:6, such as from 1:1.5 to 1:5, such as from 1:1.5 to 1:4, such as from 1:1.5 to 1:3, such as from 1:1.5 to 1:2.
- the particulate material is cork.
- the weight ratio of the cork to tobacco material in the smokeless oral tobacco product is from 1:1.5 to 1:10, such as from 1:1.5 to 1:9, such as from 1:1.5 to 1:8, such as from 1:1.5 to 1:7, such as from 1:1.5 to 1:6, such as from 1:1.5 to 1:5, such as from 1: 1.5 to 1:4, such as from 1:1.5 to 1:3, such as from 1:1.5 to 1:2.
- the particulate material is included in an amount of from 1 to 80% by weight of the smokeless oral tobacco product, such as in an amount of from 2 to 80% by weight of the smokeless oral tobacco product, such as in an amount of from 3 to 80% by weight of the smokeless oral tobacco product, such as in an amount of from 4 to 80% by weight of the smokeless oral tobacco product, such as in an amount of from 5 to 80% by weight of the smokeless oral tobacco product, such as in an amount of from 5 to 75% by weight of the smokeless oral tobacco product, such as in an amount of from 5 to 70% by weight of the smokeless oral tobacco product, such as in an amount of from 5 to 65% by weight of the smokeless oral tobacco product, such as in an amount of from 5 to 60% by weight of the smokeless oral tobacco product, such as in an amount of from 5 to 55% by weight of the smokeless oral tobacco product, such as in an amount of from 5 to 50% by weight of the smokeless oral tobacco product, such as in an amount of from 5 to 45% by weight of the smokeless
- the particulate material is cork.
- the cork is included in an amount of from 1 to 80% by weight of the smokeless oral tobacco product, such as in an amount of from 2 to 80% by weight of the smokeless oral tobacco product, such as in an amount of from 3 to 80% by weight of the smokeless oral tobacco product, such as in an amount of from 4 to 80% by weight of the smokeless oral tobacco product, such as in an amount of from 5 to 80% by weight of the smokeless oral tobacco product, such as in an amount of from 5 to 75% by weight of the smokeless oral tobacco product, such as in an amount of from 5 to 70% by weight of the smokeless oral tobacco product, such as in an amount of from 5 to 65% by weight of the smokeless oral tobacco product, such as in an amount of from 5 to 60% by weight of the smokeless oral tobacco product, such as in an amount of from 5 to 55% by weight of the smokeless oral tobacco product, such as in an amount of from 5 to 50% by weight of the smokeless oral tobacco product, such as in an amount
- the particulate material does not interfere with the aroma/smell of the tobacco material.
- cork is advantageously neutral in aroma, and does not interfere with the aroma/smell of the tobacco material, and therefore does not adversely affect the user experience.
- An advantage of the present invention is that the amount of tobacco used in the smokeless oral tobacco products according to the present invention may be reduced whilst maintaining the organoleptic properties of the products.
- the use of the particulate material having the properties described herein in the present invention may advantageously increase the release of components from the tobacco material, such as flavour and/or nicotine, in the smokeless oral tobacco product, which may enhance user experience.
- the inclusion of the particulate material having the properties described herein results in a less dense smokeless oral tobacco product, which has a more open structure. This may result in more free movement of fluid in the tobacco product and in the mouth, and subsequently may result in improved release of components from the smokeless oral tobacco product.
- the present inventors have surprisingly found that modifying the weight ratio of the particulate material included in the smokeless oral tobacco product results in a modification of the density and compactness of the product, and thereby may enable regulation of the extraction rate of the flavour and nicotine.
- Another advantage of the present invention is the ability to regulate the amount of tobacco provided to the user without adversely affecting the user experience.
- smokeless oral tobacco products which are provided in portions (optionally in pouches)
- the use of the particulate material having the properties described herein in the present invention enables a decrease in the overall density of the smokeless oral tobacco product compared to conventional smokeless oral tobacco products which do not comprise the particulate material. Therefore, it has surprisingly been found that the weight of a portion of the product may be varied whilst maintaining the overall size of the portion provided to the user. For example, the weight of the product may be reduced without any corresponding reduction in the volume of the product.
- a further advantage of the present invention is the ability to reduce the amount of irritation at the back of the throat perceived by the consumer during use of the product.
- One problem associated with smokeless oral tobacco products is the sensitisation of a nerve at the back of the throat of a user which occurs during use. This may result in an irritation at the back of the throat, commonly referred to by consumers as "drip". It has surprisingly been found that the inclusion of the particulate material in accordance with the present invention results in a product which is perceived by the consumer as being drier relative to standard oral tobacco products not comprising the particulate material, and also reduces the perceived extent of irritation at the back of the throat of a user of the smokeless oral tobacco product.
- the particulate material which is a hydrophobic particulate material selected from the group consisting of cork, sawdust, millet husks, polystyrene, sodium alginate microspheres, foamed alginates, and mixtures thereof, having the following properties:
- the particulate material which is a hydrophobic particulate material selected from the group consisting of cork, sawdust, millet husks, polystyrene, sodium alginate microspheres, foamed alginates, and mixtures thereof having the following properties:
- the smokeless oral tobacco products of the present invention have an improved mouthfeel compared with smokeless oral tobacco products which do not comprise the particulate material having the properties described herein.
- the improved mouthfeel is due to the improved flexibility and improved shape retention during use of the products of the present invention.
- the amount of tobacco in the smokeless oral tobacco products may be varied without any adverse effect on the total volume of product provided to the user, and with an improvement in the mouthfeel of the product.
- the smokeless oral tobacco product may comprise a high nicotine content tobacco. Therefore, the overall nicotine content of the smokeless oral tobacco product may be maintained despite use of lower amounts of tobacco by weight.
- the nicotine content of the tobacco material is from 0.02% to 7.5% by weight of the tobacco material. In some embodiments, the nicotine content of the tobacco material is from 0.03% to 7.5% by weight of the tobacco material, such as from 0.04% to 7.5% by weight of the tobacco material, such as from 0.05% to 7.5% by weight of the tobacco material, such as from 0.06% to 7.5% by weight of the tobacco material, such as from 0.07% to 7.5% by weight of the tobacco material, such as from 0.08% to 7.5% by weight of the tobacco material, such as from 0.09% to 7.5% by weight of the tobacco material, such as from 0.1% to 7.5% by weight of the tobacco material, such as from 0.1% to 7% by weight of the tobacco material.
- the smokeless oral tobacco product may further comprise other components. These components may, for example, be included in order to alter the organoleptic properties of the formulation, contributing to the sensory perception by the consumer.
- the particular components and the amounts in which they are included in the smokeless oral tobacco product of the present invention will vary depending upon the desired flavour, texture, and other characteristics.
- flavouring agents for example, flavouring agents, preservatives, binders, humectants, buffering agents, disintegration aids and/or colourants may be included in the smokeless oral tobacco product.
- the terms "flavour” and “flavourant” refer to materials which, where local regulations permit, may be used to create a desired taste or aroma in a product for adult consumers. They may include extracts (e.g., licorice, hydrangea, Japanese white bark magnolia leaf, chamomile, fenugreek, clove, menthol, Japanese mint, aniseed, cinnamon, herb, wintergreen, cherry, berry, peach, apple, Drambuie, bourbon, scotch, whiskey, spearmint, peppermint, lavender, cardamom, celery, cascarilla, nutmeg, sandalwood, bergamot, geranium, honey essence, rose oil, vanilla, lemon oil, orange oil, cassia, caraway, cognac, jasmine, ylang-ylang, sage, fennel, piment, ginger, anise, coriander, coffee, or a mint oil from any species of the genus Mentha
- the present invention also provides a consumer package comprising the smokeless oral tobacco product as described herein.
- the smokeless oral tobacco product is non-portioned, and the consumer package comprises a container, such as a box or a can.
- the smokeless oral tobacco product is portioned.
- the portioned smokeless oral tobacco product may be provided in a pouch.
- a pouch comprising the smokeless oral tobacco product as described herein.
- the present invention also provides a method of manufacturing a smokeless oral tobacco product comprising a tobacco material and a particulate material, wherein the particulate material is a hydrophobic particulate material selected from the group consisting of cork, sawdust, millet husks, polystyrene, sodium alginate microspheres, foamed alginates, and mixtures thereof, the particulate material having the following properties:
- the blend of tobacco particles may be mixed with water and, typically, salt. Residual moisture from the tobacco and the added water combine to raise the moisture levels of the mixture to at least 20%, and in some embodiments to at least 25%, and in some embodiments to about 20 to 60%, and in some embodiments to about 25 to 60%. Salt is one form of flavourant; optionally it may be excluded and/or another flavourant may be added at this stage.
- the tobacco blend may be mixed with water and/or salt either prior to the processing step (b), during the processing step (b) or after the processing step (b). In one embodiment, the tobacco blend is mixed with water, and optionally salt, prior to the processing step (b).
- the tobacco formulation is particulate, comprising tobacco particles having a mass median particle size measured by sieve analysis of from about 0.01-1 mm, for example, a mass median particle size of about 0.1-0.5 mm, or a mass median particle size of about 0.25-0.4 mm.
- the particulate tobacco comprises a mixture of tobacco stem particles and tobacco lamina particles. In some embodiments, the particulate tobacco comprises tobacco stem particles in an amount of from 5% to 70% by weight of the combined amount of tobacco stem particles and tobacco lamina particles.
- the particulate snus tobacco may be humidified to 20 to 50% moisture, and/or may be salted. In embodiments wherein the tobacco comprises particulate snus, the particulate snus tobacco may be humidified to about 50% moisture, and/or may be salted.
- the amount of tobacco within the tobacco formulation may vary. In some embodiments, the amount of tobacco within the tobacco formulation is at least about 25% on a wet weight basis, such as at least about 30% on a wet weight basis, such as at least about 40% on a wet weight basis.
- the tobacco blend (together with any water and salt) is heat treated for a period of time long enough and at a temperature high enough to meet the demands for pasteurisation.
- the tobacco blend is typically heat treated for one hour to meet the demands for pasteurisation.
- the heat treatment can take any form which is sufficient to produce a product having an acceptably low level of spoilage microorganisms.
- the heat treatment may meet the demands for pasteurisation, and thus may take a form that results in sterilisation of the product.
- Examples include high or low temperatures; e.g., heat treatment at about 80-140°C for about at least 30 minutes via hot air, steam, microwaves, or other means, or cold pasteurisation. Other examples include irradiation and chemical treatment.
- heat treatment method selected is that it is appropriate for use with a product intended for human oral consumption. Another is that is should not present undue adverse effect on the taste, consistency or other organoleptic properties of the final smokeless oral tobacco product.
- the heat treatment also gives texture and colour to the mixture.
- the heat treatment step will comprise ensuring the tobacco replacement or substitute is not contaminated with microorganisms, and that this step may not require any other manipulation of the product.
- a pH of approximately 7 to 12 may be preferred at this stage of the process.
- the heat treated blend may optionally be matured. This may be done by slowly mixing the blend while holding it at a constant temperature such as approximately 40-75°C, preferably at about 50°C. The gentle stirring can continue for about 1 to 24 hours, particularly for about 3 to 15 hours. This stage may be effective at reducing pH and possibly reducing moisture to about 20-55% based on the weight of the smokeless oral tobacco product, depending on the type of tobacco used and the particular snus product being manufactured.
- a flavourant may be added during the maturation stage.
- the flavourant added at this stage is in a liquid form and is added to about 0.1-5% by weight of the smokeless oral tobacco product.
- the liquid flavourant is often sprayed onto the tobacco blend.
- humectants are traditionally added at this stage as well.
- flavourants and other additives may be added to the tobacco blend before or after pasteurisation and/or maturation.
- flavourants and other additives such as preservatives, binders, humectants, buffering agents, disintegration aids and colourants
- the particulate material may be added to the tobacco material prior to, during or after heat treatment. In some embodiments, the particulate material is added prior to the heat treatment step. In some embodiments, the particulate material is added during the heat treatment step. In some embodiments, the particulate material is added after the heat treatment step.
- the particulate material is mixed with the tobacco material prior to heat treatment so that the particulate material is heat treated in the same manner as the tobacco material.
- Example 1 Measurement of mass median particle size of sample
- the above-identified test sieving equipment is shown in Figure 2 , and comprises 10 sieves having the following mesh sizes: Sieve Number Mesh Size ( ⁇ m) 1 1000 2 900 3 800 4 710 5 600 6 500 7 400 8 180 9 90 10 ⁇ 90
- the mean cumulative mass of the samples was calculated to be 49.77g.
- FIG. 4 A graph plotting percentage cumulative mass (y-axis) against mesh size or each sieve (x-axis) is shown in Figure 4 .
- a linear line of best-fit has been drawn through a number of the data points.
- Example 1b Measurement of mass median particle size of millet husks
- Example 1a The same method as described in Example 1a was used to determine the mass median particle size of a sample of millet husks.
- the mean cumulative mass of the samples was calculated to be 50.17g.
- a graph plotting percentage cumulative mass (y-axis) against mesh size (x-axis) is shown in Figure 5 .
- a linear line of best-fit has been drawn through a number of the data points.
- a snus batch was made using a 60:40 weight ratio (tobacco:cork) of pre-treated materials by adding 3,600g of tobacco and 2,400g of cork (cork granules at 0.055-0.060g/cm 3 bulk density; mass median particle size approximately 0.55-0.65 mm, supplied by Cork Link, Portugal), water, sodium chloride, and other ingredients to a horizontal, cylindrical, ploughshare mixer. The mix of ingredients was then stirred, and heat applied for a long enough duration to ensure safe microbiological status of snus. Following heat treatment, the product had a maturation period of several hours at elevated temperature with continuous intermittent stirring at low speed of mixer blades inside the mixer. The processing was finished by adding flavour, adjusting pH to about 8.5 by adding sodium carbonate, and water content measured to ensure that end moisture content was 45% (w/w).
- Finished cork-containing snus was then transferred to plastic bags, and allowed to mature in a cold room for one week. Following this, snus was packed to pouches using a Mertz snus packer (Merzmaschinen GmbH, Visualstra ⁇ e 25, D-35423 Lich, Germany), and bulk density was measured. Bulk density was measured using an Engelsmann Jolting Voltumeter STAV II. Bulk density was calculated pre-jolting, for a given volume of a certain mass of particulate material.
- a snus batch containing an 80:20 tobacco:cork weight ratio was prepared and analysed using the method of Example 2, where 4,000g of tobacco was added to the mixture, and 1,000g of cork added.
- a snus batch containing a 95:5 tobacco:cork weight ratio was prepared and analysed using the method of Example 2, where 4,750g of tobacco was added to the mixture, and 250g of cork added.
- a snus batch containing no cork (i.e. a tobacco:cork weight ratio of 100:0) was prepared and analysed using the method of Example 2, where 5,000g of tobacco was added to the mixture, and 0g of cork added.
- Table 1 Measured bulk densities and pouch weights of cork-containing snus of a standard White snus blend at 45% moisture, with varying levels of cork Example Cork (% w/w) Bulk Density (g/cm 3 ) Mass of pouch (g) 2 40 0.207 0.4 3 20 0.260 0.5 4 5 0.350 0.6 5 0 0.425 0.8
- the stated level of cork does not refer to the ratio of cork in the final snus product as this depends on moisture level and other ingredients.
- the final weight percentage of cork is around 18-20% w/w.
- the amount of cork is specified as a ratio of total ground, pre-treated tobacco mix, prior to any other ingredients having been added.
- Example 2 The products of Examples 2 and 5 are shown in Figure 6 , where the product comprising 40% w/w cork (Example 2) is shown on the left hand side, and the product comprising 0% w/w cork (Example 5) is shown on the right hand side.
- the product comprising 40% w/w cork (Example 2) had a bulk density 51.3% lower than the product comprising 0% w/w of cork (Example 5) for the same weight of product.
- a standard snus product contains 0.9g of tobacco.
- 0.9g of the snus product according to Example 5 having 0% w/w cork has a volume calculated as 1.8cm 3 .
- the weight of the snus product according to Example 2 comprising 40% w/w cork required to fill a volume of 1.8cm 3 is 0.3726g. This results in a 58.6% reduction in material weight for the same volume.
- cork has a neutral aroma and taste, and thus did not add any noticeable aromas or tastes to the tobacco products.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Manufacture Of Tobacco Products (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21159251.4A EP3847904A1 (en) | 2016-03-07 | 2017-03-02 | Smokeless oral product and preparation thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1603866.3A GB201603866D0 (en) | 2016-03-07 | 2016-03-07 | Smokeless oral tobacco product and preperation thereof |
PCT/GB2017/050559 WO2017153718A1 (en) | 2016-03-07 | 2017-03-02 | Smokeless oral tobacco product and preparation thereof |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21159251.4A Division EP3847904A1 (en) | 2016-03-07 | 2017-03-02 | Smokeless oral product and preparation thereof |
EP21159251.4A Division-Into EP3847904A1 (en) | 2016-03-07 | 2017-03-02 | Smokeless oral product and preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3426064A1 EP3426064A1 (en) | 2019-01-16 |
EP3426064B1 true EP3426064B1 (en) | 2021-04-28 |
Family
ID=55859082
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21159251.4A Pending EP3847904A1 (en) | 2016-03-07 | 2017-03-02 | Smokeless oral product and preparation thereof |
EP17709761.5A Active EP3426064B1 (en) | 2016-03-07 | 2017-03-02 | Smokeless oral tobacco product and preparation thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21159251.4A Pending EP3847904A1 (en) | 2016-03-07 | 2017-03-02 | Smokeless oral product and preparation thereof |
Country Status (12)
Country | Link |
---|---|
US (1) | US20190124971A1 (hu) |
EP (2) | EP3847904A1 (hu) |
JP (2) | JP6725164B2 (hu) |
CA (1) | CA3016766C (hu) |
DK (1) | DK3426064T3 (hu) |
ES (1) | ES2886799T3 (hu) |
GB (1) | GB201603866D0 (hu) |
HU (1) | HUE055099T2 (hu) |
PL (1) | PL3426064T3 (hu) |
RU (1) | RU2698489C1 (hu) |
UA (1) | UA126790C2 (hu) |
WO (1) | WO2017153718A1 (hu) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113924004B (zh) * | 2019-06-07 | 2023-11-03 | 菲利普莫里斯生产公司 | 烟碱袋组合物 |
DK180339B1 (en) * | 2019-06-07 | 2020-12-18 | Ncp Nextgen As | Nicotine pouch composition and pouch comprising such |
US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
US11617744B2 (en) | 2019-12-09 | 2023-04-04 | Nico Ventures Trading Limited | Moist oral compositions |
US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
US20210169123A1 (en) * | 2019-12-09 | 2021-06-10 | Nicoventures Trading Limited | Pouched products with enhanced flavor stability |
GB201918973D0 (en) * | 2019-12-20 | 2020-02-05 | Nicoventures Trading Ltd | Particle |
EP3874970A1 (en) * | 2020-03-03 | 2021-09-08 | Reemtsma Cigarettenfabriken GmbH | Filling material for an oral pouched smokeless product and oral pouched smokeless product manufactured therefrom |
US20240008522A1 (en) * | 2020-11-18 | 2024-01-11 | Nicoventures Trading Limited | Oral products |
EP4018846B1 (en) * | 2020-12-22 | 2024-09-18 | Swedish Match North Europe AB | A pouched product for oral use comprising a liquid permeable cover material and a filling material comprising a first type of particles |
EP4018847B1 (en) * | 2020-12-22 | 2024-09-18 | Swedish Match North Europe AB | A pouched product for oral use |
EP4018848B1 (en) * | 2020-12-22 | 2024-09-18 | Swedish Match North Europe AB | A pouched product for oral use comprising a liquid permeable cover material and a filling material |
EP4018849B1 (en) * | 2020-12-22 | 2024-10-23 | Swedish Match North Europe AB | A pouched product for oral use |
EP4035540A1 (en) * | 2021-01-29 | 2022-08-03 | Swedish Match North Europe AB | Method for producing a snuff composition for oral use and a snuff composition produced by the method |
MX2023015529A (es) * | 2021-06-25 | 2024-03-05 | Nicoventures Trading Ltd | Productos orales y metodo de fabricacion. |
US11510870B1 (en) | 2021-08-31 | 2022-11-29 | Jackie L. White | Substrates for vaporizing and delivering an aerosol |
WO2023210814A1 (ja) * | 2022-04-28 | 2023-11-02 | 日本たばこ産業株式会社 | 無機多孔質材料を含む口腔用組成物 |
WO2023210813A1 (ja) * | 2022-04-28 | 2023-11-02 | 日本たばこ産業株式会社 | 無機多孔質材料を含む口腔用組成物 |
WO2024089588A1 (en) * | 2022-10-24 | 2024-05-02 | Nicoventures Trading Limited | Shaped pouched products |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101873809B (zh) * | 2007-07-23 | 2014-11-12 | R.J.雷诺兹烟草公司 | 无烟烟草组合物 |
US20100116281A1 (en) * | 2008-11-07 | 2010-05-13 | Jerry Wayne Marshall | Tobacco products and processes |
US9675102B2 (en) * | 2010-09-07 | 2017-06-13 | R. J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
US8931493B2 (en) * | 2010-11-01 | 2015-01-13 | R.J. Reynolds Tobacco Co. | Smokeless tobacco products |
US20150004281A1 (en) | 2011-12-16 | 2015-01-01 | Wm. Wrigley Jr. Company | Low density chewing gum and method of making same |
GB2501092A (en) | 2012-04-11 | 2013-10-16 | British American Tobacco Co | Oral tobacco product |
US20130298920A1 (en) * | 2012-05-08 | 2013-11-14 | Steven G. Lance | Smokeless tobacco analogue and method of use |
GB201222986D0 (en) * | 2012-12-20 | 2013-01-30 | British American Tobacco Co | Smokeless oral tobacco product and preparation thereof |
-
2016
- 2016-03-07 GB GBGB1603866.3A patent/GB201603866D0/en not_active Ceased
-
2017
- 2017-03-02 DK DK17709761.5T patent/DK3426064T3/da active
- 2017-03-02 CA CA3016766A patent/CA3016766C/en active Active
- 2017-03-02 RU RU2018132019A patent/RU2698489C1/ru active
- 2017-03-02 WO PCT/GB2017/050559 patent/WO2017153718A1/en active Application Filing
- 2017-03-02 US US16/083,127 patent/US20190124971A1/en active Pending
- 2017-03-02 EP EP21159251.4A patent/EP3847904A1/en active Pending
- 2017-03-02 EP EP17709761.5A patent/EP3426064B1/en active Active
- 2017-03-02 ES ES17709761T patent/ES2886799T3/es active Active
- 2017-03-02 PL PL17709761.5T patent/PL3426064T3/pl unknown
- 2017-03-02 HU HUE17709761A patent/HUE055099T2/hu unknown
- 2017-03-02 JP JP2018545320A patent/JP6725164B2/ja active Active
- 2017-03-02 UA UAA201809138A patent/UA126790C2/uk unknown
-
2020
- 2020-06-22 JP JP2020107041A patent/JP6931110B2/ja active Active
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
CA3016766A1 (en) | 2017-09-14 |
EP3847904A1 (en) | 2021-07-14 |
GB201603866D0 (en) | 2016-04-20 |
HUE055099T2 (hu) | 2021-10-28 |
ES2886799T3 (es) | 2021-12-20 |
JP6725164B2 (ja) | 2020-07-15 |
CA3016766C (en) | 2022-11-01 |
JP2020162618A (ja) | 2020-10-08 |
DK3426064T3 (da) | 2021-06-28 |
JP2019512219A (ja) | 2019-05-16 |
WO2017153718A1 (en) | 2017-09-14 |
PL3426064T3 (pl) | 2023-06-12 |
US20190124971A1 (en) | 2019-05-02 |
RU2698489C1 (ru) | 2019-08-28 |
UA126790C2 (uk) | 2023-02-08 |
JP6931110B2 (ja) | 2021-09-01 |
EP3426064A1 (en) | 2019-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3426064B1 (en) | Smokeless oral tobacco product and preparation thereof | |
EP2836088B1 (en) | A smokeless tobacco composition comprising non-tobacco fibers and a method for its manufacture | |
US10874134B2 (en) | Smokeless oral tobacco product and preparation thereof | |
RU2294674C2 (ru) | Табачное изделие, содержащее растительный материал из мяты | |
WO2008056135A2 (en) | A smokeless tobacco product and method for forming such a product | |
US20070062549A1 (en) | Smokeless tobacco composition | |
WO2009056611A2 (en) | Smokeless oral tobacco blends and methods for making the same | |
AU2004285589A1 (en) | Flavored smokeless tobacco and methods of making | |
WO2016132532A1 (ja) | 口腔用たばこ組成物及びsnus | |
CA2980256A1 (en) | Method for producing a pouched smokeless tobacco product comprising heat treatment | |
EP2742813A1 (en) | A smoking article, such as a cigar, with flavoured mouthpiece and method for manufacturing such article | |
RU2428888C1 (ru) | Способ изготовления бездымного табачного изделия (варианты) | |
RU2478321C1 (ru) | Способ изготовления нюхательного табака | |
CN118749701A (zh) | 能释放二氧化碳气体加速尼古丁释放的口含烟内含物颗粒的制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20181008 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20200930 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BRITISH AMERICAN TOBACCO (INVESTMENTS) LIMITED Owner name: FIEDLER & LUNDGREN AB |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: SOFFE, JOANNA DAWN Inventor name: GUSTAFSON, JOHAN ROBERT Inventor name: MOLA, MICHELE |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1386090 Country of ref document: AT Kind code of ref document: T Effective date: 20210515 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602017037544 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: RO Ref legal event code: EPE |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 Effective date: 20210621 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NO Ref legal event code: T2 Effective date: 20210428 |
|
REG | Reference to a national code |
Ref country code: HU Ref legal event code: AG4A Ref document number: E055099 Country of ref document: HU |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210428 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210428 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210428 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210728 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210428 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210830 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210828 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210428 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210729 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2886799 Country of ref document: ES Kind code of ref document: T3 Effective date: 20211220 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210428 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210428 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210428 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602017037544 Country of ref document: DE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: UEP Ref document number: 1386090 Country of ref document: AT Kind code of ref document: T Effective date: 20210428 |
|
26N | No opposition filed |
Effective date: 20220131 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210828 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210428 |
|
REG | Reference to a national code |
Ref country code: HU Ref legal event code: HC9C Owner name: FIEDLER & LUNDGREN AB, SE Ref country code: HU Ref legal event code: HC9C Owner name: BRITISH AMERICAN TOBACCO (INVESTMENTS) LIMITED, GB |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210428 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220302 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220302 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230504 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20240320 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20240321 Year of fee payment: 8 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210428 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210428 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: RO Payment date: 20240227 Year of fee payment: 8 Ref country code: HU Payment date: 20240322 Year of fee payment: 8 Ref country code: DE Payment date: 20240320 Year of fee payment: 8 Ref country code: CZ Payment date: 20240227 Year of fee payment: 8 Ref country code: GB Payment date: 20240320 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20240320 Year of fee payment: 8 Ref country code: PL Payment date: 20240219 Year of fee payment: 8 Ref country code: NO Payment date: 20240322 Year of fee payment: 8 Ref country code: IT Payment date: 20240322 Year of fee payment: 8 Ref country code: FR Payment date: 20240328 Year of fee payment: 8 Ref country code: DK Payment date: 20240326 Year of fee payment: 8 Ref country code: BE Payment date: 20240320 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20240401 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20240429 Year of fee payment: 8 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210428 |